Company Information

METROPOLIS HEALTHCARE LTD.

NSE : METROPOLISBSE : 542650ISIN CODE : INE112L01020Industry : Hospital & Healthcare ServicesHouse : Metropolis
BSE1791.90-47.75 (-2.6 %)
PREV CLOSE ( ) 1839.65
OPEN PRICE ( ) 1832.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11648
TODAY'S LOW / HIGH ( )1753.20 1837.65
52 WK LOW / HIGH ( )1209.25 1935
NSE1771.65-69.35 (-3.77 %)
PREV CLOSE( ) 1841.00
OPEN PRICE ( ) 1829.00
BID PRICE (QTY) 1771.65 (755)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 348884
TODAY'S LOW / HIGH( ) 1752.05 1839.00
52 WK LOW / HIGH ( )1209.25 1933.5
ChairmanSushil Kanubhai Shah
Managing DirectorAmeera Sushil Shah
Company SecretaryKamlesh Kulkarni
Non Executive Independent DirectorVivek Gambhir
Sanjay Bhatnagar
Anita Ramachandran
Subramanian Ranganathan
Non Independent & Non Executive DirectorHemant Sachdev
Incorporation Year : 10-11 2000

Registered Office :

Address : 4th Floor, East Wing, Plot-254 B,Nirlon House, Dr. Annie Besant Road,Worli Mumbai,
Maharashtra-400030 .

Phone : 022 6258 2810 / 8422 801 801

Industry : Hospital & Healthcare Services

Listing : BSE,NSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.